<VariationArchive VariationID="634903" VariationName="NM_000094.4(COL7A1):c.1319del (p.Glu440fs)" VariationType="Deletion" Accession="VCV000634903" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-30" DateCreated="2019-06-22" MostRecentSubmission="2019-06-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="622742" VariationID="634903">
      <GeneList>
        <Gene Symbol="COL7A1" FullName="collagen type VII alpha 1 chain" GeneID="1294" HGNC_ID="HGNC:2214" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48564073" stop="48595329" display_start="48564073" display_stop="48595329" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48601505" stop="48632592" display_start="48601505" display_stop="48632592" Strand="-" />
          </Location>
          <OMIM>120120</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000094.4(COL7A1):c.1319del (p.Glu440fs)</Name>
      <CanonicalSPDI>NC_000003.12:48591935:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48591936" stop="48591936" display_start="48591936" display_stop="48591936" variantLength="1" positionVCF="48591935" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48629369" stop="48629369" display_start="48629369" display_stop="48629369" variantLength="1" positionVCF="48629368" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E440fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48629369del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48629369del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48591936del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48591936del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007065.1" sequenceAccession="NG_007065" sequenceVersion="1" change="g.8317del">
            <Expression>NG_007065.1:g.8317del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.4" sequenceAccession="NM_000094" sequenceVersion="4" change="c.1319del" MANESelect="true">
            <Expression>NM_000094.4:c.1319del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000085.1" sequenceAccession="NP_000085" sequenceVersion="1" change="p.Glu440fs">
            <Expression>NP_000085.1:p.Glu440fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_286" sequenceAccession="LRG_286">
            <Expression>LRG_286:g.8317del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.3" sequenceAccession="NM_000094" sequenceVersion="3" change="c.1319delA">
            <Expression>NM_000094.3:c.1319delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1559435706" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000094.4(COL7A1):c.1319del (p.Glu440fs) AND Recessive dystrophic epidermolysis bullosa" Accession="RCV000785757" Version="1">
        <ClassifiedConditionList TraitSetID="5728">
          <ClassifiedCondition DB="MedGen" ID="C0079474">Recessive dystrophic epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-06-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-06-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-06-22" MostRecentSubmission="2019-06-22">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5728" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1160" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">severe generalized recessive dystrophic epidermolysis bullosa</ElementValue>
                <Citation Type="general">
                  <ID Source="PubMed">18374450</ID>
                </Citation>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Distrophica Autosomal Recessive (RDEB)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0024" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0036" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0037" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0025" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Recessive dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Recessive+dystrophic+epidermolysis+bullosa/9208" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009179" DB="MONDO" />
                <XRef ID="48528004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hallopeau-Siemens Disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RDEB</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EBR1</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6308" />
                <XRef ID="6308" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79408" DB="Orphanet" />
              <XRef ID="79409" DB="Orphanet" />
              <XRef ID="C0079474" DB="MedGen" />
              <XRef ID="MONDO:0009179" DB="MONDO" />
              <XRef Type="MIM" ID="226600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1807455" SubmissionDate="2019-06-17" DateLastUpdated="2019-06-22" DateCreated="2019-06-22">
        <ClinVarSubmissionID localKey="SUB5822718" submittedAssembly="GRCh37" title="SUB5822718" />
        <ClinVarAccession Accession="SCV000924301" DateUpdated="2019-06-22" DateCreated="2019-06-22" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Heterozygous variant c.1319delA (p.Glu440GlyfsTer27) in exon 10 has been observed in COL7A1 gene. The proband is consanguineously married; her two daughters had blisters all over the body and were diagnosed with dystrophica epidermolysis bullosa and expired at an early age. The patient in our clinical analysis was diagnosed with the said variant in an autosomal recessive mode of inheritance. The variant has not been reported in the 1000 genomes and ExAC databases. The in-silico prediction of the variant is possibly damaging by MutationTaster2. In summary, the said variant meets our criteria to be classified as pathogenic based on the mode of inheritance, in silico prediction and allele frequency in population databases.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Indian Hindu</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina Sequencing Platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA was used to perform targeted gene sequencing using a custom capture kit. Libraries were sequenced to mean &gt;80-100X coverage in Illumina sequencing platform. Sequence obtained were aligned to a human reference genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication.</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Epidermolysis bullosa panel genes (Carrier screening)</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2019-06-13">Foundation for Research in Genetics and Endocrinology</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0008066" />
              </Trait>
              <Comment>Clinical features observed in two daughters</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1">
              <Name>collagen type VII alpha 1 chain</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000094.3:exon 10</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">D-4628</Name>
            <Name>p.Glu440GlyfsTer27</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.1319delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226600" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5822718</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1807455" TraitType="Disease" MappingType="XRef" MappingValue="226600" MappingRef="OMIM">
        <MedGen CUI="C0079474" Name="Recessive dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807455" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008066" MappingRef="HP">
        <MedGen CUI="C2132198" Name="Abnormal blistering of the skin" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

